TY - JOUR
T1 - Diagnosis of hypersensitivity pneumonitis in adults
T2 - An official ATS/JRS/ALAT clinical practice guideline
AU - American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax
AU - Raghu, Ganesh
AU - Wilson, Kevin C.
AU - Bargagli, Elena
AU - Bendstrup, Elisabeth
AU - Chami, Hassan A.
AU - Chua, Abigail T.
AU - Chung, Jonathan H.
AU - Collins, Bridget F.
AU - Corte, Tamera J.
AU - Dalphin, Jean Charles
AU - Danoff, Sonye K.
AU - Diaz, Javier Mendoza
AU - Duggal, Abhijit
AU - Egashira, Ryoko
AU - Ewing, Thomas
AU - Gulati, Mridu
AU - Inoue, Yoshikazu
AU - Jenkins, Alex R.
AU - Johannson, Kerri A.
AU - Johkoh, Takeshi
AU - Kitaichi, Masanori
AU - Knight, Shandra L.
AU - Koschel, Dirk
AU - Kreuter, Michael
AU - Lederer, David J.
AU - Mageto, Yolanda
AU - Maier, Lisa A.
AU - Matiz, Carlos
AU - Morell, Ferran
AU - Myers, Jeffrey L.
AU - Nicholson, Andrew G.
AU - Patolia, Setu
AU - Pereira, Carlos A.
AU - Remy, Martine Jardin
AU - Renzoni, Elisabetta A.
AU - Ryerson, Christopher J.
AU - Salisbury, Margaret L.
AU - Selman, Moises
AU - Tamae, Maximiliano Kakazu
AU - Vasakova, Martina
AU - Walsh, Simon L.F.
AU - Wuyts, Wim A.
N1 - Publisher Copyright:
Copyright © 2020 by the American Thoracic Society.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax. Methods: Systematic reviews were performed for six questions. Theevidencewas discussed, andthenrecommendations were formulated by amultidisciplinary committee of experts in the field of interstitial lung disease and HP using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach. Results: The guideline committee defined HP, and clinical, radiographic, andpathological features were described.HPwas classified into nonfibrotic and fibrotic phenotypes. There was limited evidence that was directly applicable to all questions. The need for a thorough history and a validated questionnaire to identify potential exposureswas agreed on. Serum IgG testing against potential antigens associated with HP was suggested to identify potential exposures. For patients with nonfibrotic HP, a recommendation was made in favor of obtaining bronchoalveolar lavage (BAL) fluid for lymphocyte cellular analysis, and suggestions for transbronchial lung biopsy and surgical lung biopsywere also made. For patients with fibrotic HP, suggestionsweremade in favor of obtaining BAL for lymphocyte cellular analysis, transbronchial lung cryobiopsy, and surgical lung biopsy. Diagnostic criteria were established, and a diagnostic algorithmwas created by expert consensus. Knowledge gaps were identified as future research directions. Conclusions: The guideline committee developed a systematic approach to the diagnosis of HP. The approach should be reevaluated as new evidence accumulates.
AB - Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax. Methods: Systematic reviews were performed for six questions. Theevidencewas discussed, andthenrecommendations were formulated by amultidisciplinary committee of experts in the field of interstitial lung disease and HP using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach. Results: The guideline committee defined HP, and clinical, radiographic, andpathological features were described.HPwas classified into nonfibrotic and fibrotic phenotypes. There was limited evidence that was directly applicable to all questions. The need for a thorough history and a validated questionnaire to identify potential exposureswas agreed on. Serum IgG testing against potential antigens associated with HP was suggested to identify potential exposures. For patients with nonfibrotic HP, a recommendation was made in favor of obtaining bronchoalveolar lavage (BAL) fluid for lymphocyte cellular analysis, and suggestions for transbronchial lung biopsy and surgical lung biopsywere also made. For patients with fibrotic HP, suggestionsweremade in favor of obtaining BAL for lymphocyte cellular analysis, transbronchial lung cryobiopsy, and surgical lung biopsy. Diagnostic criteria were established, and a diagnostic algorithmwas created by expert consensus. Knowledge gaps were identified as future research directions. Conclusions: The guideline committee developed a systematic approach to the diagnosis of HP. The approach should be reevaluated as new evidence accumulates.
KW - Fibrotic hypersensitivity pneumonitis
KW - Hypersensitivity pneumonitis
KW - Interstitial lung disease
KW - Nonfibrotic hypersensitivity pneumonitis
KW - Pulmonary fibrosis
UR - https://www.scopus.com/pages/publications/85089126056
U2 - 10.1164/rccm.202005-2032ST
DO - 10.1164/rccm.202005-2032ST
M3 - Review article
C2 - 32706311
AN - SCOPUS:85089126056
SN - 1073-449X
VL - 202
SP - E36-E69
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 3
ER -